Published in J Infect Dis on January 01, 1971
Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev (2004) 7.51
Surface parasitism by Mycoplasma pneumoniae of respiratory epithelium. J Exp Med (1977) 5.35
Attachment of Mycoplasma pneumoniae to respiratory epithelium. Infect Immun (1976) 4.35
Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob Agents Chemother (1995) 3.22
Experimental Mycoplasma pulmonis infection in pathogen-free mice. Models for studying mycoplasmosis of the respiratory tract. Am J Pathol (1973) 2.14
Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother (2006) 1.94
Cytotoxicity of Mycoplasma pneumoniae Membranes. Infect Immun (1974) 1.72
Opsonin-reversible resistance of Mycoplasma pneumoniae to in vitro phagocytosis by alveolar macrophages. Infect Immun (1975) 1.60
The interaction in vitro between polymorphonuclear leukocytes and mycoplasma. J Exp Med (1971) 1.50
Parameters of Mycoplasma pneumoniae infection in Syrian hamsters. Infect Immun (1988) 1.44
Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile. Infect Immun (2001) 1.44
Demonstration of antibodies to Mycoplasma pneumoniae attachment protein in human sera and respiratory secretions. Infect Immun (1983) 1.44
Molecular distinctions among clinical isolates of Mycoplasma pneumoniae. J Clin Microbiol (1990) 1.43
Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect Immun (1995) 1.36
Isolation of binding sites to glycophorin from Mycoplasma pneumoniae membranes. Infect Immun (1980) 1.35
Identification of a possible cytadherence regulatory locus in Mycoplasma pneumoniae. Infect Immun (1995) 1.35
Mycoplasma pneumoniae respiratory disease symposium: summation and significance. Yale J Biol Med (1984) 1.34
Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease. Infect Immun (2002) 1.26
Mutant analysis reveals a specific requirement for protein P30 in Mycoplasma pneumoniae gliding motility. J Bacteriol (2005) 1.20
Causes of atypical pneumonia: results of a 1-year prospective study. Can Med Assoc J (1981) 1.20
Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae. J Clin Microbiol (1992) 1.18
Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of aerosol particle size and site of deposition of M. pneumoniae on the pattern of respiratory infection, disease, and immunity in hamsters. Infect Immun (1977) 1.18
Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr (2012) 1.17
In vitro response of human lymphocytes to Mycoplasma pneumoniae. Infect Immun (1972) 1.17
A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995. Eur J Epidemiol (1997) 1.17
Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of route of administration on the immunogenicity and protective effect of inactivated M. pneumoniae vaccine. Infect Immun (1977) 1.15
Phosphorylation of cytadherence-accessory proteins in Mycoplasma pneumoniae. J Bacteriol (1994) 1.14
Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia. Antimicrob Agents Chemother (2003) 1.07
Mycoplasma pneumonia with fulminant evolution into diffuse interstitial fibrosis. Thorax (1980) 1.07
Mycoplasma pneumoniae infections in children. Arch Dis Child (1978) 1.06
Stability and subcellular localization of cytadherence-associated protein P65 in Mycoplasma pneumoniae. J Bacteriol (2001) 1.05
Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection. Antimicrob Agents Chemother (2004) 1.05
Ultrastructural observations on cellular and subcellular aspects of experimental Mycoplasma pneumoniae disease. Infect Immun (1980) 1.02
Ultrastructural changes in hamster tracheal ring cultures exposed to Mycoplasma pneumoniae. Am J Pathol (1973) 1.02
Resistance to mycoplasmal lung disease in mice is a complex genetic trait. Infect Immun (1996) 0.99
Mycoplasma pneumoniae in hamster tracheal organ culture studied by scanning electron microscopy. Infect Immun (1976) 0.97
Freeze-fracture confirmation of the presence of a core in the specialized tip structure of Mycoplasma pneumoniae. J Bacteriol (1983) 0.93
Experimental infection of the respiratory tract with Mycoplasma pneumoniae. Environ Health Perspect (1980) 0.91
Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model. J Infect Dis (2011) 0.91
Epidemic caprine keratoconjunctivitis: experimentally induced disease with a pure culture of Mycoplasma conjunctivae. Infect Immun (1977) 0.90
Phosphorylation of Mycoplasma pneumoniae cytadherence-accessory proteins in cell extracts. J Bacteriol (1995) 0.89
Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother (2009) 0.88
Changes in the epidemiological pattern of Mycoplasma pneumoniae infections in Denmark. A 30 years survey. Epidemiol Infect (1988) 0.86
Parasitism of hamster trachea epithelial cells by Mycoplasma pneumoniae. Infect Immun (1988) 0.85
Ten and a half years seroepidemiology of Mycoplasma pneumoniae infection in Denmark. Epidemiol Infect (1991) 0.84
Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications. Front Microbiol (2014) 0.83
Human diseases associated with mycoplasms. With an appendix on simple culture techniques. Calif Med (1972) 0.83
Mycoplasma pneumoniae vaccine: antigenicity of buffered antigens in volunteers. Infect Immun (1972) 0.83
Seroreactivity to Mycoplasma pneumoniae and Legionella pneumophila: lack of a statistically significant relationship. J Clin Microbiol (1981) 0.82
Fatal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl. Wien Klin Wochenschr (2007) 0.82
Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses. Thorax (1998) 0.81
Immunoblot analyses of chimpanzee sera after infection and after immunization and challenge with Mycoplasma pneumoniae. Infect Immun (1994) 0.80
Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy. Int J Mol Sci (2017) 0.80
Epidemiologic aspects of M. pneumoniae disease complications: a review. Yale J Biol Med (1984) 0.79
Interaction of Mycoplasma pneumoniae with HeLa cells. Infect Immun (1988) 0.79
Location of attachment moiety on Mycoplasma pneumoniae. Yale J Biol Med (1984) 0.78
Mycoplasmal pneumonia and adult respiratory distress syndrome: a complication to be recognized. J Natl Med Assoc (1981) 0.78
A protocol for minor respiratory illnesses. An evaluation of its use by nurses in a prepaid group practice. Public Health Rep (1977) 0.78
Mycoplasma pneumoniae infections of adults and children. West J Med (1976) 0.77
Role of Atypical Pathogens and the Antibiotic Prescription Pattern in Acute Bronchitis: A Multicenter Study in Korea. J Korean Med Sci (2015) 0.77
Inflammation-inducing Factors of Mycoplasma pneumoniae. Front Microbiol (2016) 0.77
An unrecognized epidemic of Mycoplasma pneumoniae infection in Vienna. Wien Klin Wochenschr (2006) 0.76
Clinical features of mycoplasmal pneumonia in adults. Yale J Biol Med (1984) 0.75
Introduction acute respiratory infections in military personnel. Yale J Biol Med (1975) 0.75
Cranial sixth-nerve palsy and eosinophilia in an outbreak of Mycoplasma pneumonia. Can Fam Physician (1987) 0.75
Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia. Korean J Pediatr (2017) 0.75
The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med (2001) 7.49
Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child (1986) 7.39
Epidemiology of acute lower respiratory disease in children. N Engl J Med (1973) 5.58
Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med (1979) 5.44
Mycoplasma pneumoniae infection: role of a surface protein in the attachment organelle. Science (1982) 5.08
Relationships Between Mycoplasma pneumoniae and Human Respiratory Epithelium. Infect Immun (1971) 4.14
Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev (1982) 4.03
Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr (1981) 4.00
Mortality and influenza. J Infect Dis (1982) 3.98
Characteristics of virulent, attenuated, and avirulent Mycoplasma pneumoniae strains. J Bacteriol (1969) 3.96
Interpandemic influenza in the Houston area, 1974-76. N Engl J Med (1978) 3.92
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA (1999) 3.53
Biologic effects of Mycoplasma pneumoniae and other mycoplasmas from man on hamster tracheal organ culture. Proc Soc Exp Biol Med (1969) 3.53
Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis (1981) 3.30
The interrelationship of virulence, cytadsorption, and peroxide formation in Mycoplasma pneumoniae. Proc Soc Exp Biol Med (1969) 3.17
Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr (1971) 2.75
Appearance of Mycoplasma pneumoniae in lungs of experimentally infected hamsters and sputum from patients with natural disease. Am Rev Respir Dis (1974) 2.74
A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med (1982) 2.52
Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis (1980) 2.50
Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis (1984) 2.31
The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J Pediatr (1979) 2.30
Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J Pediatr (1975) 2.29
Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis (1997) 2.09
Effect of a toxin produced by Haemophilus influenzae on ciliated respiratory epithelium. J Infect Dis (1974) 2.01
Respiratory disease in group day care. Pediatrics (1972) 2.01
Acute lower respiratory tract infections in nonhospitalized children. J Pediatr (1986) 2.01
Characterization of hemadsorption-negative mutants of Mycoplasma pneumoniae. Infect Immun (1981) 2.00
Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis (1996) 1.98
Evaluation of a home-based intervention program to reduce infant passive smoking and lower respiratory illness. J Behav Med (1994) 1.97
Pneumonia: an eleven-year study in a pediatric practice. Am J Epidemiol (1981) 1.91
Croup: an 11-year study in a pediatric practice. Pediatrics (1983) 1.90
Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease. Infect Immun (1970) 1.90
Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis (1987) 1.84
The effect of antibiotics on Mycoplasma pneumoniae in vitro and in vivo. Am J Epidemiol (1967) 1.81
Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. Am J Epidemiol (1980) 1.74
The influenza herald wave. Am J Epidemiol (1982) 1.74
Influenza in children. Relationship to other respiratory agents. JAMA (1980) 1.73
Mycoplasma pneumoniae in hamster tracheal organ culture: immunofluorescent and electron microscopic studies. Proc Soc Exp Biol Med (1971) 1.71
A new animal model for human respiratory tract disease due to adenovirus. J Infect Dis (1984) 1.71
The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice. J Med Microbiol (1972) 1.69
Physical properties of human Mycoplasma species. J Bacteriol (1966) 1.68
Dual respiratory virus infections. Clin Infect Dis (1997) 1.67
Immunoglobulin-containing cells in lungs of hamsters infected with Mycoplasma pneumoniae. J Immunol (1972) 1.67
Spectrum of clinical illness in hospitalized patients with "common cold" virus infections. Clin Infect Dis (2000) 1.66
Influenza: its control in persons and populations. J Infect Dis (1986) 1.65
Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis (1993) 1.65
Opsonin-reversible resistance of Mycoplasma pneumoniae to in vitro phagocytosis by alveolar macrophages. Infect Immun (1975) 1.60
Immunopathology of experimental Mycoplasma pneumoniae disease. Infect Immun (1971) 1.58
Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child (1990) 1.56
Antigenic determinants of the attachment protein of Mycoplasma pneumoniae shared by other pathogenic Mycoplasma species. Infect Immun (1986) 1.55
Nature of the immune response to Mycoplasma pneumoniae. J Immunol (1967) 1.55
Serum cotinine as a measure of tobacco smoke exposure in children. Am J Dis Child (1985) 1.54
A Mycoplasma genitalium protein resembling the Mycoplasma pneumoniae attachment protein. Infect Immun (1987) 1.52
Epidemiology of colonization by nontypable Haemophilus influenzae in children: a longitudinal study. J Infect Dis (1986) 1.50
Factors influencing growth inhibition of Mycoplasma pneumoniae by immune sera. Proc Soc Exp Biol Med (1967) 1.50
Group A streptococci, mycoplasmas, and viruses associated with acute pharyngitis. JAMA (1967) 1.47
Maternal immunization against viral disease. Vaccine (1998) 1.47
Acute respiratory infections are the leading cause of death in children in developing countries. Am J Trop Med Hyg (1986) 1.46
Infection with influenza A/Victoria virus in Houston families, 1976. J Hyg (Lond) (1981) 1.44
Demonstration of antibodies to Mycoplasma pneumoniae attachment protein in human sera and respiratory secretions. Infect Immun (1983) 1.44
Reinfection with influenza A (H3N2) virus in young children and their families. J Infect Dis (1979) 1.41
Respiratory infections due to Mycoplasma pneumoniae in infants and children. Pediatrics (1975) 1.41
Priorities for the use of finite resources: now may be the time to choose. J Pediatr (1989) 1.39
The unusual severity of Mycoplasmal pneumonia in children with sickle-cell disease. N Engl J Med (1972) 1.35
Mycoplasma pneumoniae respiratory disease symposium: summation and significance. Yale J Biol Med (1984) 1.34
Influenza B virus infections in the community and the family. The epidemics of 1976-1977 and 1979-1980 in Houston, Texas. Am J Epidemiol (1983) 1.32
Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. J Infect Dis (1987) 1.30
Salmonella in two poultry processing plants. J Am Vet Med Assoc (1966) 1.27
Breast-feeding and respiratory virus infection. Pediatrics (1982) 1.25
A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease. Pediatr Infect Dis J (2001) 1.24
Neurological syndromes and mycoplasmal infections. Arch Neurol (1980) 1.24
Antipyretic use among children during the 1983 influenza season. Am J Dis Child (1985) 1.22
The Epidemiology and Prevention of Rheumatic Fever. Bull N Y Acad Med (1952) 1.22
Considerations of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis (1980) 1.20
Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine (2001) 1.20
The epidemiology of bronchiolitis. Pediatr Res (1977) 1.20
A solid-phase radioimmunoassay for detection of antibodies against Mycoplasma pneumoniae. J Clin Lab Immunol (1983) 1.17
A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995. Eur J Epidemiol (1997) 1.17
Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis (1991) 1.16